Boston Scientific Corporation
BSX
Peringkat dalam Saham
#409
Deskripsi perusahaan ini hanya tersedia dalam bahasa Inggris.
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Harga Saham
$41.88
Terakhir disinkronkan: 2026-10-30
Kapitalisasi Pasar
$60.69B
Perubahan (1 hari)
-1.89%
Perubahan (1 tahun)
-58.42%
Negara
US
Data saham: Financial Modeling PrepΒ·Diperbarui Β·Bukan saran investasiΒ·Cara kami menghitung
Perdagangan Boston Scientific Corporation (BSX)
Kategori
Healthcare
Rasio P/E untuk Boston Scientific Corporation (BSX)
Rasio P/E per November 2026 TTM: 17.71
Menurut laporan keuangan dan harga saham terbaru dari Boston Scientific Corporation, rasio P/E saat ini (TTM) adalah 17.71. Pada akhir 2025, perusahaan memiliki rasio P/E sebesar 48.65.
Riwayat rasio P/E untuk Boston Scientific Corporation dari 2000 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Perubahan |
|---|---|---|
| 2026 (TTM) | 17.71 | -63.59% |
| 2025 | 48.65 | -31.38% |
| 2024 | 70.89 | 34.45% |
| 2023 | 52.73 | -44.39% |
| 2022 | 94.83 | 63.23% |
| 2021 | 58.10 | -109.35% |
| 2020 | -621.10 | -4,739.24% |
| 2019 | 13.39 | -54.16% |
| 2018 | 29.21 | -91.06% |
| 2017 | 326.58 | 285.92% |
| 2016 | 84.63 | -182.61% |
| 2015 | -102.44 | -30.52% |
| 2014 | -147.45 | 10.67% |
| 2013 | -133.23 | 6,624.20% |
| 2012 | -1.98 | -110.84% |
| 2011 | 18.28 | -269.40% |
| 2010 | -10.79 | -18.52% |
| 2009 | -13.24 | 132.42% |
| 2008 | -5.70 | -83.69% |
| 2007 | -34.93 | 471.06% |
| 2006 | -6.12 | -118.98% |
| 2005 | 32.22 | 15.12% |
| 2004 | 27.99 | -56.60% |
| 2003 | 64.49 | 39.54% |
| 2002 | 46.22 | -124.91% |
| 2001 | -185.54 | -1,347.09% |
| 2000 | 14.88 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 39.33 | 122.06% |
US
|
|
| 23.60 | 33.26% |
IE
|
|
| 30.88 | 74.36% |
US
|
|
| 21.66 | 22.29% |
DE
|
|
| 52.88 | 198.53% |
US
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.
Pertanyaan tentang rasio P/E Boston Scientific Corporation
Berapa rasio P/E Boston Scientific Corporation?
Per Nov 2026, rasio P/E Boston Scientific Corporation sebesar 17.71.
Berapa rasio P/E Boston Scientific Corporation pada tahun 2025?
Pada tahun 2025, rasio P/E Boston Scientific Corporation sebesar 48.65, dibandingkan 70.89 pada tahun 2024.
Bagaimana perubahan rasio P/E Boston Scientific Corporation sejak tahun 2020?
Dari tahun 2020 hingga 2025, rasio P/E Boston Scientific Corporation tertinggi pada tahun 2022 (94.83) dan terendah pada tahun 2020 (-621.10).
Bagaimana rasio P/E Boston Scientific Corporation dibandingkan dengan perusahaan sejenis?
Dengan 17.71, rasio P/E Boston Scientific Corporation lebih rendah daripada semua 5 perusahaan sejenis yang tercantum di atas. Yang tertinggi di antara perusahaan tersebut adalah Edwards Lifesciences Corporation, dengan 52.88.